@article{26b10df46a824754a706e8486462b2bb,
title = "Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism",
abstract = "The folate-driven one-carbon (1C) cycle is a fundamental metabolic hub in cells that enables the synthesis of nucleotides and amino acids and epigenetic modifications. This cycle might also release formaldehyde, a potent protein and DNA crosslinking agent that organisms produce in substantial quantities. Here we show that supplementation with tetrahydrofolate, the essential cofactor of this cycle, and other oxidation-prone folate derivatives kills human, mouse and chicken cells that cannot detoxify formaldehyde or that lack DNA crosslink repair. Notably, formaldehyde is generated from oxidative decomposition of the folate backbone. Furthermore, we find that formaldehyde detoxification in human cells generates formate, and thereby promotes nucleotide synthesis. This supply of 1C units is sufficient to sustain the growth of cells that are unable to use serine, which is the predominant source of 1C units. These findings identify an unexpected source of formaldehyde and, more generally, indicate that the detoxification of this ubiquitous endogenous genotoxin creates a benign 1C unit that can sustain essential metabolism.",
author = "Guillermo Burgos-Barragan and Niek Wit and Johannes Meiser and Dingler, {Felix A.} and Matthias Pietzke and Lee Mulderrig and Pontel, {Lucas B.} and Rosado, {Ivan V.} and Brewer, {Thomas F.} and Cordell, {Rebecca L.} and Monks, {Paul S.} and Chang, {Christopher J.} and Alexei Vazquez and Patel, {Ketan J.}",
note = "Funding Information: Acknowledgements We thank C. Knox and the LMB mouse facility, the LMB FACS facility and G. MacKay and D. Sumpton from the Beatson Metabolomics Unit. We thank H. Koyama for providing us with the FANCB-deficient NALM-6 strain. We are grateful to T. Elliott and A. Liang for assistance with the LMB LC–MS analyses. G.B.B. was funded by the CRUK Cambridge Cancer Centre studentship and the Wellcome Trust. N.W. was funded by Children With Cancer and the Wellcome Trust. L.B.P. was funded by the Wellcome Trust. F.A.D. and L.M. were funded by CRUK. I.V.R. was funded by BFU2013-42918-P, AES15/01409 (CP12/03273), European Union (FEDER) and RYC-2015-18670. We thank the NIH (GM 79465 and ES004705 to C.J.C.) for support of this work. C.J.C. is an Investigator of the Howard Hughes Medical Institute. T.F.B. was partially supported by a Chemical Biology Training Grant from the NIH (T32 GM066698). R.L.C. and P.S.M. are supported by the MRC. R.L.C. is also supported by the EPSRC. J.M., M.P. and A.V. were funded by CRUK (C596/A21140 and C596/ A18076). J.M. was also funded by a DFG Fellowship (ME 4636/2-1). K.J.P. is supported by the Medical Research Council, CRUK and the Wellcome Trust. Publisher Copyright: {\textcopyright} 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.",
year = "2017",
month = aug,
day = "31",
doi = "10.1038/nature23481",
language = "English",
volume = "548",
pages = "549--554",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7669",
}